Noroozzadeh M, Tehrani F Ramezani, Mobarakabadi S Sedigh, Farahmand M, Dovom M Rostami
Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Impot Res. 2017 Jan;29(1):1-6. doi: 10.1038/ijir.2016.35. Epub 2016 Sep 22.
There is no consensus regarding the impact of polycystic ovary syndrome (PCOS) and its hormonal profile on sexual function of affected women; majority of data documented are not population based and there is a lack of studies investigating the association between hormonal profiles with sexual function in women with PCOS. We aimed to compare the sexual function of PCOS women with controls in a population-based study based on their hormonal profiles. In this cross-sectional study, sexual function (using the Female Sexual Function Index (FSFI) questionnaire) and hormonal profiles were determined in 63 PCOS subjects and 216 healthy women (controls); aged 18-45 years. A comparison of PCOS women and controls showed no statistically significant difference in total FSFI and each of its specific domain scores. There were significant positive correlations between dehydroepiandrosterone sulfate and total FSFI, orgasm and satisfaction domains in controls (r=0.156, r=0.206, r=0.275, respectively). No significant correlations between hormonal profiles and FSFI scores were found in the PCOS group, except for prolactin and orgasm (r=-0.250). In conclusion, sexual function did not differ between PCOS women and controls. High levels of androgens in women with PCOS were not associated with an improvement in sexual function.
关于多囊卵巢综合征(PCOS)及其激素水平对受影响女性性功能的影响,目前尚无共识;大多数已记录的数据并非基于人群,且缺乏对PCOS女性激素水平与性功能之间关联的研究。我们旨在通过一项基于人群的研究,根据激素水平比较PCOS女性与对照组的性功能。在这项横断面研究中,对63名PCOS受试者和216名18至45岁的健康女性(对照组)测定了性功能(使用女性性功能指数(FSFI)问卷)和激素水平。PCOS女性与对照组的比较显示,FSFI总分及其各个特定领域得分在统计学上无显著差异。在对照组中,硫酸脱氢表雄酮与FSFI总分、性高潮和满意度领域之间存在显著正相关(分别为r = 0.156、r = 0.206、r = 0.275)。在PCOS组中,除催乳素与性高潮(r = -0.250)外,未发现激素水平与FSFI评分之间存在显著相关性。总之,PCOS女性与对照组的性功能无差异。PCOS女性体内高水平的雄激素与性功能改善无关。